CyberKnife Boost for Locally Advanced Lung Cancer

Locally Advanced NSCLC Treated With Radiochemotherapy: Phase 2 Study on the Value of a Stereotactic Boost

Recruiting Phase 2 Interventional Study
Carcinoma, Non-Small-Cell Lung
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Trial phase
Phase 2
Study type
Interventional
Purpose
Treatment
Participants needed
42 (estimated)
Sponsor
Centre Antoine Lacassagne · Other
Who this trial is looking for

This trial is looking for adults with a specific type of lung cancer who cannot have surgery right now. Participants will receive chemotherapy and radiation treatment, with the chance of an additional CyberKnife radiation boost.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am 18 years old or older
  • I have been diagnosed with non-small cell lung cancer
  • I have stage III lung cancer that cannot be operated on
  • I have received specific chemotherapy and radiation treatments
  • I have a CT scan of my chest showing my tumor size
  • I can safely have a venous device implanted
  • I can read information about the trial and give my consent
  • I have a negative pregnancy test if applicable

You may not be able to join if

  • I have a positive EGFR mutation
  • I have severe heart failure or related breathing problems
  • I have had heart problems in the last three months
  • My lung function tests show I cannot receive radiation
  • I have side effects from previous treatments that prevent further radiation
  • I am pregnant or breastfeeding and do not meet specific criteria
  • I cannot give consent or am under legal protection

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This is a monocentric, non-randomized, open-label, superiority phase II clinical investigation evaluating the efficacy of additional Cyberknife irradiation after a doublet of Platinum Salts-based chemotherapy and concomitant radiotherapy in patients with locally advanced non-small cell lung carcinoma (NSCLC), with an interim analysis.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Patients aged 18 years old or more 2. ECOG 0 to 2 3. Histologically proven non-small cell lung cancer 4. Stage III non-metastatic tumor, not allowing for immediate surgery 5. Volume(s) on the evaluation chest CT scan done at the end of conventional radiotherapy (between 34 \&…
Contacts

Study coordinator

+33 04 92 03 16 61

DRCI-Promotion@nice.unicancer.fr

CONTACT